Sports genetic platform Athletigen raises $1.55 mln in financing
Halifax, Nova Scotia-based Athletigen Technologies Inc, a sports genetics technology company, has secured $1.55 million in seed-stage financing. Exponential Partners, a U.S. venture capital firm, led the round. In addition to the funding, Pat Wilkison of Exponential Partners, has been named to the company's board of directors. Founded in 2014, Athletigen said it planned to use the investment's proceeds to support the growth of its Athletigen Performance Platform, a tool used by athletes, including those preparing for the 2016 Olympic Games in Rio de Janeiro, Brazil.
4 January 2016•3 mins read
